Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | XENE | ACHR |
|---|---|---|
| Price | $37.57 | $4.72 |
| Change today | ▼ 1.18% | ▼ 3.48% |
| Market cap | $3.64B | $3.63B |
| Return, 3 months | -40.7% | -4.3% |
| Return, year to date | -16.2% | -37.2% |
| Return, 1 year | -5.0% | -65.4% |
| P/E (TTM) | -7.9 | -4.4 |
| P/B | 2.9 | 1.9 |
| P/E percentile vs own 5y | 100th | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | -47.6% | – |
| Gross margin | – | – |
| Operating margin | -4,974.3% | – |
| Net margin | -4,612.1% | – |
| Return on equity | -43.6% | – |
| Analyst target vs. price | +97.0% | +145.8% |
| Analyst buy share | 100% | 83% |
| RSI (14) | 24 | 33 |
| 30-day volatility | 111.7% | 45.2% |
| Max drawdown, 1 year | -48.5% | -67.4% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
